We observed that low stroke risk patients exhibited higher GATA-3, Foxp3, PU.1, AHR, IL-9, IL-10 and IL-22 expression levels than did patients with high stroke risk (Fig 3A and 3B). This evidence concerns the gene SPI1 and stroke disorder.